UNFPA Armenia Presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report
By Public Radio of Armenia,
Public Radio of Armenia
| 12. 19. 2011
Prof. Razmik Abrahamyan, Director of Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology, and Mr. Garik Hayrapetyan, UNFPA Armenia Assistant Representative presented the “Prevalence and Reasons of Sex Selective Abortions in Armenia” Report today.
As the speakers noted, the report contained both positive and alarming findings. In particular, the majority of the surveyed women have started having children in a favorable reproductive age: from 19 to 35 years old, which is very important in terms of safe motherhood. Another extremely positive finding is that the Armenian society provides the same care to already born children irrespective of their sex.
However, as to the future children, the society prefers boys much more than girls – around six times. The study suggests that 0.8 per cent of 900,000 Armenian women of reproductive age have had a sex selective abortion in the last five years. This means that each year Armenia potentially loses around 1400 future mothers.
According to the speakers, the report is based on the findings of a quantitative survey of 2830 households in the period of July 15-August 15, 2011...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
